Circulation. 2008;117:1897-1907
Published online before print March 17, 2008,
doi: 10.1161/CIRCULATIONAHA.107.188950
(Circulation. 2008;117:1897-1907.)
© 2008 American Heart Association, Inc.
Management of Cocaine-Associated Chest Pain and Myocardial Infarction
A Scientific Statement From the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology
James McCord, MD;
Hani Jneid, MD;
Judd E. Hollander, MD;
James A. de Lemos, MD;
Bojan Cercek, MD, FAHA;
Priscilla Hsue, MD;
W. Brian Gibler, MD;
E. Magnus Ohman, MD;
Barbara Drew, RN, PhD, FAHA;
George Philippides, MD;
L. Kristin Newby, MD, MHS
Key Words: AHA Scientific Statement cocaine substance-related disorders myocardial infarction
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
The goals of the present article are to provide a critical review
of the literature on cocaine-associated chest pain and myocardial
infarction (MI) and to give guidance for diagnostic and therapeutic
interventions. Classification of recommendations and levels
of evidence are expressed in the American College of Cardiology/American
Heart Association (ACC/AHA) format as follows:
- Class I: Conditions for which there is evidence for and/or general agreement that the procedure or treatment is beneficial, useful, and effective.
- Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.
- Class IIa: Weight of evidence/opinion is in favor of usefulness/efficacy.
- Class IIb: Usefulness/efficacy is less well established by evidence/opinion.
- Class III: Conditions for which there is evidence and/or general agreement that the procedure/treatment is not useful/effective and in some cases may be harmful.
- Level of Evidence A: Data derived from multiple randomized clinical trials.
- Level of Evidence B: Data derived from a single randomized trial or nonrandomized studies.
- Level of Evidence C: Only consensus opinion of experts, case studies, or standard of care.
 |
Methods
|
|---|
The Writing Committee conducted a comprehensive search of the
medical literature concerning cocaine-associated chest pain
and MI. The literature search included English-language publications
on humans and animals from 1960 to 2007. In addition to broad-based
searching concerning cocaine, specific targeted searches were
performed on cocaine and the following topics: MI, chest pain,
emergency department (ED), aspirin, nitroglycerin, calcium channel
blocker,
. . . [Full Text of this Article]
This article has been cited by other articles:

|
 |

|
 |
 
S. Martin-Schild, K. C. Albright, V. Misra, M. Philip, A. D. Barreto, H. Hallevi, J. C. Grotta, and S. I. Savitz
Intravenous Tissue Plasminogen Activator in Patients With Cocaine-Associated Acute Ischemic Stroke
Stroke,
November 1, 2009;
40(11):
3635 - 3637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O Fayomi
Management of cocaine-associated chest pain
Emerg. Med. J.,
October 1, 2009;
26(10):
760 - 760.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Zimmerman
Poisonings and Overdoses
ACCP Crit Care Med Brd Rev,
January 1, 2009;
20(0):
341 - 356.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H Wu
Cardiotoxic drugs: clinical monitoring and decision making
Heart,
November 1, 2008;
94(11):
1503 - 1509.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Management of Cocaine-Associated Chest Pain and MI
Journal Watch Emergency Medicine,
May 23, 2008;
2008(523):
3 - 3.
[Full Text]
|
 |
|

|
 |

|
 |
 
Guidelines: MI and Chest Pain Associated with Cocaine Use
Journal Watch Cardiology,
April 16, 2008;
2008(416):
2 - 2.
[Full Text]
|
 |
|